Also refers to the throw itself as the ball goes far past or "over" the intended target. P
Pace bowling (also fast bowling)
a style of bowling in which the ball is delivered at high speeds, typically over 90 mph (145 km/h). A pace bowler (or paceman) often will also use swing. Pads
protective equipment for batsmen and wicket-keepers, covering the legs. Pad away or pad-play 
to intentionally use the pads deflect the ball away from the wicket. Using the pad instead of the bat removes the danger of being caught by close fielders, but would only be used when there is no risk of being dismissed LBW (for example, if the ball pitched on the leg side). Paddle sweep
A very fine sweep, almost just a tickle of the delivery pitched on or outside leg stump. Paddle scoop
(also known as a scoop shot, ramp shot, Dilscoop or Marillier shot)
A shot in which the batsman drops on one knee and scoops the ball over their shoulder or head, using the bat as ramp to redirect the momentum of the ball. Considered unorthodox and risky, but can result in a boundary behind the wicketkeeper or in the fine leg region. Pair
a "pair of spectacles" (0–0) or a "pair of ducks". A batsmans score of nought (zero) runs in both innings of a two-innings match (see this list of Pairs in test and first-class cricket).
Tolerance, dependence, and withdrawal
A benzodiazepine dependence occurs in about one-third of individuals who are treated with benzodiazepines for longer than 4 weeks, which typically results in tolerance and benzodiazepine withdrawal syndrome when the dose is reduced too rapidly. Midazolam infusions may induce tolerance and a withdrawal syndrome in a matter of days. The risk factors for dependence include dependent personality, use of a benzodiazepine that is short-acting, high potency and long-term use of benzodiazepines. Withdrawal symptoms from midazolam can range from insomnia and anxiety to seizures and psychosis. Withdrawal symptoms can sometimes resemble a persons underlying condition. Gradual reduction of midazolam after regular use can minimise withdrawal and rebound effects. Tolerance and the resultant withdrawal syndrome may be due to receptor down-regulation and GABAA receptor alterations in gene expression, which causes long-term changes in the function of the GABAergic neuronal system.Chronic users of benzodiazepine medication who are given midazolam experience reduced therapeutic effects of midazolam, due to tolerance to benzodiazepines. Prolonged infusions with midazolam results in the development of tolerance; if midazolam is given for a few days or more a withdrawal syndrome can occur. Therefore, preventing a withdrawal syndrome requires that a prolonged infusion be gradually withdrawn, and sometimes, continued tapering of dose with an oral long-acting benzodiazepine such as clorazepate dipotassium. When signs of tolerance to midazolam occur during intensive care unit sedation the addition of an opioid or propofol is recommended. Withdrawal symptoms can include irritability, abnormal reflexes, tremors, clonus, hypertonicity, delirium and seizures, nausea, vomiting, diarrhea, tachycardia, hypertension, and tachypnea.